País: Estados Unidos
Idioma: inglés
Fuente: NLM (National Library of Medicine)
ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E)
RPK Pharmaceuticals, Inc.
ALBUTEROL SULFATE
ALBUTEROL 90 ug
RESPIRATORY (INHALATION)
PRESCRIPTION DRUG
PROAIR HFA Inhalation Aerosol is indicated for the treatment or prevention of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease. PROAIR HFA Inhalation Aerosol is indicated for the prevention of exercise-induced bronchospasm in patients 4 years of age and older. PROAIR HFA Inhalation Aerosol is contraindicated in patients with a history of hypersensitivity to albuterol and any other PROAIR HFA Inhalation Aerosol components. Rare cases of hypersensitivity reactions, including urticaria, angioedema, and rash have been reported after the use of albuterol sulfate [see Warnings and Precautions (5.6) ] . Teratogenic Effects: Pregnancy Category C: There are no adequate and well-controlled studies of PROAIR HFA Inhalation Aerosol or albuterol sulfate in pregnant women. During worldwide marketing experience, various congenital anomalies, including cleft palate and limb defects, have been reported in the offspring of patients treated with albuterol. Some of the mothers were tak
Product: 53002-1550 NDC: 53002-1550-1 200 AEROSOL, METERED in a INHALER
New Drug Application
PROAIR HFA- ALBUTEROL SULFATE AEROSOL, METERED RPK PHARMACEUTICALS, INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE PROAIR HFA SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR PROAIR HFA INHALATION AEROSOL PROAIR HFA (ALBUTEROL SULFATE) INHALATION AEROSOL INITIAL U.S. APPROVAL: 1981 INDICATIONS AND USAGE PROAIR HFA Inhalation Aerosol is a beta -adrenergic agonist indicated for: • • DOSAGE AND ADMINISTRATION For oral inhalation only • • • • • DOSAGE FORMS AND STRENGTHS Inhalation Aerosol: Each actuation delivers 108 mcg of albuterol sulfate from the actuator mouthpiece (equivalent to 90 mcg of albuterol base). Supplied in 8.5-g canister containing 200 actuations. (3) CONTRAINDICATIONS Hypersensitivity to albuterol and any other PROAIR HFA Inhalation Aerosol Components. (4) WARNINGS AND PRECAUTIONS • • • • • • • ADVERSE REACTIONS Most common adverse reactions (≥3.0% and >placebo) are headache, tachycardia, pain, dizziness, pharyngitis, and rhinitis. (6 .1) TO REPORT SUSPECTED ADVERSE REACTIONS, CONTACT TEVA RESPIRATORY, LLC AT 1-888-482-9522 OR FDA AT 1- 800-FDA-1088 OR WWW.FDA.GOV/MEDWATCH. DRUG INTERACTIONS • • 2 Treatment or prevention of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease. (1.1) Prevention of exercise-induced bronchospasm in patients 4 years of age and older. (1.2) Treatment or prevention of bronchospasm in adults and children 4 years of age and older: 2 inhalations every 4 to 6 hours. In some patients, one inhalation every 4 hours may be sufficient. (2.1) Prevention of exercise-induced bronchospasm in adults and children 4 years of age and older: 2 inhalations 15 to 30 minutes before exercise. (2.2) Priming information: Prime PROAIR HFA before using for the first time, or when the inhaler has not been used for more than 2 weeks. To prime PROAIR HFA, release 3 sprays into the air away from the face. Shake well before each spray. (2.3) Cle Leer el documento completo